SpringWorks Therapeutics, Inc.
SWTXDelisted Jul 1, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001773427
SpringWorks Therapeutics, Inc. was delisted on Jul 1, 2025; its insiders filed their last Form 4 on Jul 2, 2025; 223 institutions reported holding it in 13F filings for Q2 2025, worth $3.65B in total; Soros Fund Management was the only superinvestor holding it.
Q3 2024 vs. Q2 2024
How the institutions holding SpringWorks Therapeutics, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 209 | 2 | 226 | +19 |
| Shares | 77.2M | 5.62M | 80.8M | +9.23M (+12.9%) |
| Value | $2.91B | $211.7M | $2.59B | −$106.4M (−3.9%) |
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (41)
Institutions that held SpringWorks Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
Sold out (22)
Institutions that held SpringWorks Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Artal Group S.A. | 1,313,026 | $49.5M |
| Laurion Capital Management LP | 263,340 | $9.92M |
| Cinctive Capital Management LP | 130,545 | $4.92M |
| Castleark Management LLC | 105,160 | $3.96M |
| Driehaus Capital Management LLC | 76,650 | $2.89M |
| Sphera Funds Management Ltd. | 70,269 | $2.65M |
| Assenagon Asset Management S.A. | 50,978 | $1.92M |
| Algert Global LLC | 34,989 | $1.32M |
| FORA Capital, LLC | 17,417 | $656.1K |
| Magnetar Financial LLC | 13,338 | $502.4K |
| Allianz Asset Management GmbH | 8,000 | $301.4K |
| American Century Companies Inc | 7,733 | $291.3K |
| Calamos Advisors LLC | 7,650 | $288.2K |
| HSBC Holdings PLC | 7,357 | $274.7K |
| Pinnacle Associates Ltd | 6,920 | $260.7K |
| Pacer Advisors, Inc. | 887 | $33.4K |
| Ashton Thomas Private Wealth, LLC | 345 | $13.0K |
| SYSTM Wealth Solutions LLC | 255 | $9.61K |
| Massmutual Trust Co FSB | 86 | $3.24K |
| Itau Unibanco Holding S.A. | 32 | $1.21K |
| Innealta Capital, LLC | 32 | $1.21K |
| Allworth Financial LP | 12 | $453 |
Not filed for Q3 2024 yet (2)
Institutions that held SpringWorks Therapeutics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 5,619,260 | $211.7M |
| Institutional & Family Asset Management, LLC | 18 | $678 |